Omeros reported $50.77M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Adma Biologics ADMA:US USD 18.97M 24.11M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Cytokinetics CYTK:US USD 133.2M 33.36M
Dynavax Technologies DVAX:US USD 106.34M 21.9M
Gilead Sciences GILD:US USD 4.2B 26M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Insmed INSM:US USD 195.43M 41.89M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Knight Therapeutics Inc GUD:CN CAD 83.61M 10.69M
Macrogenics MGNX:US USD 66.69M 1.13M
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Omeros OMER:US USD 50.77M 13.33M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Pfizer PFE:US USD 19.12B 5.9B
Regulus Therapeutics RGLS:US USD 7.56M 388K
Rockwell Medical RMTI:US USD 22.4M 765K
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
United Therapeutics UTHR:US USD 201.7M 63.4M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Vital Therapies VTL:US USD 20.12M 494K
Xoma XOMA:US USD 4.82M 927K